AdvaMed Pleads Its Case on Medical Device Tariffs
AdvaMed wants to collaborate with the Trump administration to recognize and reward the unique strength of the U.S. medtech industry.
to recognize and to reward the unique strength of the U.S. medtech industry
AdvaMed President and CEO Scott Whitaker emphasized the importance of supportive policies, including fair and reciprocal tariff-free trade with key allies, addressing unfair market access barriers, and advancing domestic regulatory reforms.
- Seeking fair and reciprocal tariff-free trade with important allies
- Addressing unfair market access barriers in specific countries
- Advancing domestic regulatory reforms and procurement incentives to enhance U.S. competitiveness
Author's summary: AdvaMed seeks Trump administration support for the U.S. medtech industry.